AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Sexual Functioning After Erection Prosthesis Placement in Post Phalloplasty Transgender Persons

Recruitingn/aAges 18 Years - anyFemaleUniversity Hospital, Ghent
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to explore sexual satisfaction among transgender men and their partners following the placement of erectile prostheses after phalloplasty. While phalloplasty can create a neophallus, the lack of natural erectile tissue often necessitates the use of erectile aids, including internal prostheses. However, these prostheses, originally designed for cisgender men, face challenges when used in transgender patients, such as higher risks of complications, infections, and mechanical failures. Despite these issues, some studies report high patient satisfaction, though partner satisfaction rates are significantly lower. The study will use validated and non-validated questionnaires to assess satisfaction with various types of erectile prostheses, addressing the gap in understanding how these devices impact the sexual and relational functioning of both transgender men and their partner

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient and partner age โ‰ฅ 18 years. * Transgender or gender non-conforming individuals diagnosed according to the DSM-5 diagnostic criteria for gender dysphoria. * Patients have undergone phalloplasty as a form of genital gender affirming surgery (any type of flap combination or technique is allowed). * Erection prosthesis placement โ‰ฅ 6 months after phalloplasty, performed at the Ghent University Hospital. Any type of prosthesis is allowed. * Patient has a functional erectile prosthesis at the time of the study. Number of erectile prosthesis is not relevant for inclusion. * Patient is Dutch, English or French speaking. * Voluntary signed and written consent by patient and their optional partner. Exclusion Criteria: * Patient age \< 18 years. * Cisgender patients treated with phalloplasty and/or erection prosthesis for various reasons. * The erection prosthesis has been explanted or the current prosthesis is nonfunctional at time of data assessment. * Erection prosthesis placement \< 6 months before study start will be excluded.
๐Ÿ’Š

What it tests

  • Questionnaire
๐Ÿ“

Where

1 site
Department of Urology, University Hospital Ghent
Ghent, Belgium
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy